Maternal thrombophilia and adverse pregnancy outcome: a case-control study

Acta Haematol. 2015;133(2):242-8. doi: 10.1159/000363048. Epub 2014 Nov 15.

Abstract

Objective: To assess the risk of adverse pregnancy outcomes in patients with acquired and/or congenital thrombophilia factors.

Patients and methods: A cohort of 130 women with a history of pregnancy loss and no successful gestation were investigated for the presence of congenital and acquired thrombophilia factors, and then compared with a control group of 130 healthy women who had had at least one successful gestation and no pregnancy loss, and were screened for congenital and acquired thrombophilia factors.

Results: Acquired and congenital thrombophilia factors were found in 30 (23%) patients and in 14 (10.8%) controls (p < 0.015). The presence of ≥1 congenital thrombophilia factor was associated with pregnancy loss with an odds ratio of 2.46 (p = 0.040). Moreover, women who had had >1 early fetal loss had a 2.85-fold risk of being carriers of congenital thrombophilia factors, compared to the controls.

Conclusion: Our study showed the increased risk of miscarriage in patients with congenital thrombophilia factors and >1 early fetal loss.

Publication types

  • Clinical Trial

MeSH terms

  • Abortion, Spontaneous / diagnosis
  • Abortion, Spontaneous / epidemiology*
  • Abortion, Spontaneous / etiology
  • Adult
  • Aged
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pregnancy
  • Pregnancy Complications, Hematologic / diagnosis
  • Pregnancy Complications, Hematologic / epidemiology*
  • Pregnancy Outcome / epidemiology*
  • Risk Factors
  • Thrombophilia / congenital
  • Thrombophilia / diagnosis
  • Thrombophilia / epidemiology*